Research Article
Prognostic Significance of Percutaneous Coronary Intervention for First Acute Myocardial Infarction with Heart Failure: Five-Year Follow-Up Results
Table 1
Baseline characteristics, laboratory examinations, and echocardiographic measurements.
| | Variables | HF group (n = 97) | Non-HF group (n = 512) | P |
| | Age (Y) | 59.30 ± 11.56 | 52.07 ± 10.93 | ≤0.001 | | Sex male n (%) | 79 (81.44) | 419 (83.46) | 0.972 | | Sex female n (%) | 18 (18.55) | 83 (16.53) | 0.972 | | BMI (kg/m2) | 25.94 ± 2.38 | 25.88 ± 2.44 | 0.328 | | Systolic pressure (mmHg) | 117.98 ± 16.58 | 121.41 ± 16.63 | 0.003 | | Diastolic pressure (mmHg) | 74.51 ± 11.44 | 73.83 ± 10.80 | 0.667 | | Smoking n (%) | 61 (62.88) | 314 (62.54) | 0.682 | | Hypertension n (%) | 39 (40.20) | 263 (52.39) | 0.053 | | Diabetes n (%) | 25 (25.77) | 142 (28.28) | 0.725 | | Atrial fibrillation n (%) | 3 (3.1) | 6 (0.2) | 0.151 | | Stroke n (%) | 3 (3.1) | 13 (2.6) | 0.755 |
| | Laboratory examinations | | | | | Peak troponin I (ng/mL) | 54.00 ± 45.87 | 22.47 ± 30.47 | ≤0.001 | | Peak CKMB (ng/mL) | 161.45 ± 133.48 | 89.69 ± 114.70 | ≤0.001 | | White blood cell count (109/L) | 10.06 ± 3.65 | 8.64 ± 2.86 | 0.002 | | Neutrophil count (109/L) | 7.58 ± 3.54 | 6.42 ± 2.74 | ≤0.001 | | Platelet count (109/L) | 218.75 ± 60.05 | 207.24 ± 56.17 | 0.237 | | Hemoglobin (g/L) | 136.74 ± 21.13 | 140.61 ± 16.78 | 0.151 | | Hs-CRP (mg/L) | 16.28 ± 13.62 | 11.16 ± 11.80 | ≤0.001 | | Uric acid (μmol/L] | 328.34 ± 80.07 | 334.12 ± 95.29 | 0.592 | | Creatinine (μmol/L) | 72.94 ± 19.24 | 75.43 ± 19.32 | 0.066 | | Homocysteine (μmol/L) | 17.35 ± 8.96 | 17.64 ± 9.65 | 0.720 | | ALT (U/L) | 56.35 ± 33.79 | 41.95 ± 30.42 | 0.005 | | AST (U/L) | 178.25 ± 164.835 | 99.32 ± 114.195 | 0.029 | | Total protein (g/L) | 67.08 ± 3.97 | 66.36 ± 3.39 | 0.666 | | Total bilirubin (μmol/L) | 10.71 ± 6.17 | 9.18 ± 5.93 | 0.003 | | Urea nitrogen (mmol/L) | 3.49 ± 1.86 | 3.22 ± 1.59 | 0.490 | | Hba1c (%) | 6.51 ± 1.29 | 6.42 ± 1.28 | 0.305 | | Fasting plasma glucose (mmol/L) | 13.66 ± 5.21 | 12.16 ± 4.01 | 0.012 | | Triglycerides (mmol/L) | 3.05 ± 1.91 | 2.77 ± 1.90 | 0.539 | | HDL-C (mmol/L) | 1.82 ± 0.73 | 1.89 ± 0.69 | 0.075 | | LDL-C (mmol/L) | 2.04 ± 0.99 | 2.03 ± 1.01 | 0.953 | | Hematocrit (%) | 62.08 ± 44.18 | 52.85 ± 54.78 | 0.008 | | BNP (pg/ml) | 298.15 ± 260.99 | 230.60 ± 294.51 | 0.003 |
| | Echocardiographic measurements | | | | | LVEF (%) | 47.34 ± 8.64 | 56.49 ± 7.33 | ≤0.001 | | LVEDD (mm) | 52.81 ± 5.75 | 48.70 ± 5.11 | ≤0.001 | | LVESD (mm) | 38.81 ± 6.02 | 33.45 ± 5.52 | ≤0.001 | | Segmental wall movement abnormal | 88 (90.72) | 327 (64.49) | ≤0.001 | | Ventricular aneurysm | 10 (10.87) | 15 (3.0) | 0.019 |
|
|
BMI: body mass index; Hs-CRP: hypersensitive C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; BNP: B-type natriuretic peptide; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end systolic diameter.
|
